| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8795121 | Revista Mexicana de Oftalmología | 2017 | 9 Pages |
Abstract
PDT has been applied profitably at our hospital if we put together the global lower chance of BCVA deterioration compared to other existing studies and a reasonable annual cost, without forgetting that verteporfin can just stop loss of vision and not improving it as antiangiogenics do.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Antonio M. Garrido-Hermosilla, Eduardo Esteban-González, MarÃa J. DÃaz-Granda, Enrique RodrÃguez-de-la-Rúa-Franch,